← Back to all trials
Recruiting
NCT05647577
The Relationship Between Inflammatory ARTritis and CArdiac DIseAse
Conditions: Inflammatory Arthritis, Rheumatoid Arthritis, Spondylitis, Ankylosing, Axial Spondyloarthritis, Spondyloarthritis, Heart Failure, Ischemic Heart Disease, Valvular Heart Disease, Left Ventricular Systolic Dysfunction, Heart Failure, Systolic, Heart Failure, Diastolic, Myocardial Infarction, Myocardial Dysfunction, Cardiac Disease, Stroke
Sex: All
Ages: 18 Years – N/A
Enrollment: 1200
Sponsor: University Hospital, Gentofte, Copenhagen
Location: Denmark
Summary
The goal of this prospective cohort study is to investigate cardiac comorbidity in a random sample of approximately 1200 patients from a population of outpatients with rheumatoid arthritis and axial spondyloarthritis referred to collectively as inflammatory arthritis (IA).
The main questions it aims to answer are:Using conventional echocardiography, the investigators aim to determine the prevalence of overt and asymptomatic cardiac dysfunction in a large random sample of outpatients with IA.
Cardiac dysfunction will be evaluated by echocardiography and cardiac biomarkers (NT-pro-BNP, hs-TNT and hs-CRP).In patients without known heart disease: Using 2, 5 and 10 year follow-up, the investigators aim to examine if advanced echocardiography can be used to detect early signs of heart disease by investigating the clinical significance of adding deformation measures - alone and in combination with selected biomarkers - to conventional risk factors in the cardiac risk assessment of patients with IAParticipants will undergo an echocardiographic examination in combination with a general health assessment including obtainment of cardiac biomarkers and a electrocardiogram.Using advanced echocardiography - Tissue Doppler Imaging, 2- dimensional speckle tracking echocardiography, 3D-echocardiography and 3-dimensional speckle tracking echocardiography - the investigators also aim to compare myocardial deformation parameters of patients with IA to a gender and age matched control group without IA from the Copenhagen City Heart Study.
Eligibility Criteria
Inclusion Criteria:Persons with a diagnosis of with a confirmed diagnosis of rheumatoid Arthritis or axial spondyloarthritisExclusion Criteria:Persons not able to cooperatePersons unable understand and sign "informed consent"
Source: ClinicalTrials.gov (NCT05647577). StuddyBuddy aggregates publicly available trial information.